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OBJECTIVES We studied the effects of cardiac resynchronization therapy (CRT) on heart failure (HF)
patients with central sleep apnea (CSA).
BACKGROUND Patients with advanced HF often suffer from CSA with Cheyne-Stokes respiration. Cardiac
resynchronization therapy improves myocardial function and exercise capacity in HF patients
with conduction disturbances. The relationship between CRT and CSA is currently
unknown.
METHODS Twenty-four patients (7 females; 62  11 years) with HF, a reduced left ventricular ejection
fraction (24  6%), and left bundle branch block (QRS duration 173  22 ms) received a
CRT device. The number of apneas and hypopneas per hour (apnea-hypopnea index [AHI])
and minimal oxygen saturation (SaO2min) were quantified by cardiorespiratory polygraphy.
Fourteen patients showed CSA (AHI 5/h), and 10 patients had an AHI 5/h without
CSA. Subjective sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI).
Data were evaluated before and after 17  7 weeks of CRT.
RESULTS In patients with CSA, CRT led to a significant decrease in AHI (19.2  10.3 to 4.6  4.4,
p  0.001) and PSQI (10.4  1.6 to 3.9  2.4, p  0.001) without Cheyne-Stokes
respiration and to a significant increase in SaO2min (84 5% to 89 2%, p 0.001). There
was no significant change in AHI (1.7  0.7 to 1.5  1.6), PSQI (2.4  0.5 to 2.6  0.9),
and SaO2min (90  2% to 91  1%) in patients without CSA.
CONCLUSIONS Cardiac resynchronization therapy leads to a reduction of CSA and to increased sleep quality
in patients with HF and sleep-related breathing disorders. This may have prognostic
implications in patients receiving CRT. (J Am Coll Cardiol 2004;44:68–71) © 2004 by the
American College of Cardiology Foundationf
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natients with heart failure (HF) often present with central
leep apnea syndrome (CSA) and Cheyne-Stokes respira-
ion, which is associated with increased mortality (1,2).
Treatment with continuous positive airway pressure ven-
ilation may improve sleep disorders (3) and cardiac func-
ion (4), whereas pharmacologic therapy alone has only
inor effects (5). Atrial overdrive pacing reduces the num-
er of sleep apnea episodes in pacemaker patients without
F (6). Cardiac resynchronization therapy (CRT) improves
he hemodynamic and functional status of HF patients with
entricular conduction delay (7,8) and may reduce cardiac
ortality (9).
We conducted a prospective trial to study the effects of
RT on CSA with Cheyne-Stokes respiration in HF
atients.
ETHODS
atients. Twenty-four consecutive patients were included
n the study. Of these, 14 showed evidence of CSA and
heyne-Stokes respiration. All patients presented with
eart failure of New York Heart Association (NYHA)
From the *Department of Cardiology, and †Clinic for Psychiatry and Psychother-
py, University Hospital, RWTH, Aachen, Germany.
Manuscript received September 16, 2003; revised manuscript received March 11,
(004, accepted March 16, 2004.unctional class III, were in a clinically stable condition for
wo months or more, and took optimized heart failure
edication, including beta-blockers (n  22), angiotensin-
onverting enzyme inhibitors (n  23), diuretics (n  23),
pironolactone (n  21), and digitalis (n  17).
Cardiac resynchronization therapy was applied using left
r biventricular pacing in an atrially triggered mode. No
atient had a conventional indication for pacemaker ther-
py. Table 1 shows patient characteristics and pacemaker
evice configurations. Data were evaluated before and after
7  7 weeks of CRT.
The study was conducted in accordance with institutional
uidelines, and all patients gave written, informed consent.
leep evaluation. Sleep-related breathing disorders were
stablished by an ambulatory overnight cardiorespiratory
olygraph (Somnocheck, Weinmann, Germany), which
ecords nasal/oral airflow, chest and abdominal wall move-
ents, oxygen saturation, and heart rate. Central sleep
pnea was defined by absent chest and abdominal wall
otion and airflow for10 s, Cheyne-Stokes respiration by
eriodic occurrence of apnea and hyperventilation, and
ypopnea by a reduction in respiratory airflow of 50% for
10 s, associated with desaturation 3%. The average
umber of episodes of apnea and hypopnea per hour
apnea-hypopnea index [AHI]) was determined. A “sleep-
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July 7, 2004:68–71 Effects of CRT on CSAelated breathing disorder” was diagnosed if the AHI was
5/h (10).
The Pittsburgh Sleep Quality Index (PSQI), a retrospec-
ive self-rating questionnaire, measures the sum score of
leep quality of the last month (11). “Good” sleepers show a
lobal PSQI sum score 5.
xercise capacity, ventilatory response, and echocardio-
raphy. Cardiopulmonary exercise testing was performed
n a bicycle ergometer using a ramp increment of 10
/min. Oxygen consumption (VO2) was determined by
reath gas analysis (Jaeger Oxycon Alpha, Germany) at peak
O2 in the terminal phase of exercise and at the anaerobic
hreshold. To analyze the ventilatory response to exercise,
e calculated the slope of ventilation increase relative to
arbon dioxide production (VE/VCO2 slope) during exercise.
The 6-min walk test was performed between two points
f 45-m distance on a plane floor.
Biplane left ventricular (LV) end-diastolic and end-
ystolic volumes and ejection fraction were quantified ac-
ording to the modified Simpson’s rule by two-dimensional
chocardiography.
tatistics. Continuous data are expressed as the mean value
SD. Statistical analyses were performed with SPSS
oftware (SPSS Inc., Chicago, Illinois).
The Wilcoxon signed-rank test was applied for paired
omparisons before and during CRT. Unpaired data were
ompared by the Mann-Whitney U test. The chi-square
est was used for nominal variables. Correlation between
Abbreviations and Acronyms
AHI  apnea hypopnea index
CRT  cardiac resynchronization therapy
CSA  central sleep apnea
HF  heart failure
LV  left ventricular
NYHA  New York Heart Association
PSQI  Pittsburgh Sleep Quality Index
SaO2min  minimal oxygen saturation
VE/VCO2  slope of increase in ventilation relative to
carbon dioxide production
VO2  oxygen consumption
Table 1. Baseline Patient Characteristics and D
All Patients
(n  24)
Male/female (n) 17/7
Age (yrs) 62  11
Ischemic/nonischemic (n) 12/12
QRS complex (ms) 173  22
Body mass index (kg/m2) 25.3  2.7
Pacemaker/ICD (n) 4/20
Lateral/anterior pacing site (n) 21/3
BV/LV pacing (n) 22/2
Programmed AV delay (ms) 113  14
*Mann-Whitney U test for numerical variables and chi-squa
men/women or the mean value  SD.
AV  atrioventricular; BV  biventricular; CSA  cent
 left ventricular.easures was calculated using the Spearman rank correla-
ion. For statistical analysis, only complete data sets of single
arameters were included. A value of p  0.05 was
onsidered significant for all comparisons.
ESULTS
linical response to CRT. During CRT, NYHA func-
ional class improved from III to II in 8 patients with and in
patients without CSA, whereas it was unchanged in the
emaining 11 patients.
Table 2 shows the results of cardiopulmonary exercise
esting, 6-min walk test, and echocardiographic data.
The anaerobic threshold was indeterminable in two
atients with and two without CSA. One patient of each
roup was unable to perform cardiopulmonary exercise
esting due to noncardiac reasons. There was no correlation
f AHI with parameters of exercise testing or echocardiog-
aphy.
leep evaluation. The effects of CRT on AHI are shown
n Figure 1 and on minimal oxygen saturation (SaO2min)
nd PSQI in Table 3. Although the PSQI was reduced in all
SA patients, it was still 5 in two patients during CRT.
here was a significant correlation between the improve-
ent of AHI and PSQI (r  0.831, p  0.05) in patients
ith, but not in patients without CSA (r0.13, pNS)
uring CRT.
There was no change in body mass index or medication
nd no weight loss or exercise training that could have
nfluenced AHI in any patient during the study. No patient
eceived supplemental oxygen or continuous positive airway
ressure therapy.
ISCUSSION
n HF patients, increased LV filling pressures can lead to
ulmonary congestion and activation of pulmonary vagal
rritant receptors, provoking hyperventilation and hypocap-
ia. Central sleep apnea occurs when arterial carbon dioxide
artial pressures fall below the apneic threshold. The cycle
ength of alternating periods of hypocapnia-induced apnea
nd reflex hyperventilation (i.e., Cheyne-Stokes respiration
e Configuration
CSA
 14)
No CSA
(n  10)
p Value*
(CSA vs. No CSA)
12/2 5/5 NS
5  11 60  11 NS
10/4 2/8 0.05
7  28 168  20 NS
.6  3.3 26.5  2.3 NS
3/11 1/9 NS
13/1 8/2 NS
12/2 10/0 NS
5  15 110  13 NS
for nominal variables. Data are presented as the number of
p apnea; ICD  implantable cardioverter-defibrillator; LVevic
(n
6
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Effects of CRT on CSA July 7, 2004:68–711]) is inversely proportional to cardiac output (12) and thus
irectly related to the severity of HF. A reduced LV
unction delays the circulation time between the lungs and
he chemoreceptors (13) and increases the sensitivity of
hemoreceptors, especially to carbon dioxide (14). The
egree of carbon dioxide hypersensitivity is a major deter-
inant of Cheyne-Stokes respiration (15). An increase in
hemoreflex sensitivity is mirrored by an elevated ventilatory
esponse to exercise in HF patients (16).
Our study is the first to show that CRT improves cardiac
unction and reduces the severity of CSA with Cheyne-
tokes respiration in HF patients with a ventricular con-
uction delay. A significant decrease in AHI and a signif-
cant increase in SaO2min was observed during CRT
ithout the application of noninvasive ventilatory support.
These beneficial effects could be explained by the CRT-
elated improvement in cardiac function. It has been shown
hat CRT leads to a more efficient LV contraction (17),
ccompanied by a reduction in functional mitral regurgita-
able 2. Effects of Cardiac Resynchronization Therapy on Exerc
All Patients
(n  24)
E/VCO2 slope Pre 34.9  5.8 (n  18)
CRT 30.2  5.2* (n  18)
O2-AT (ml/min per kg) Pre 10.1  1.8 (n  18)
CRT 13.3  3.1* (n  18)
eak VO2 (ml/min per kg) Pre 12.8  3.0 (n  18)
CRT 16.7  4.8* (n  18)
-min walk test (m) Pre 302  130
CRT 386  116*
nd-diastolic volume (ml) Pre 255  78
CRT 206  88*
nd-systolic volume (ml) Pre 193  78
CRT 142  76*
jection fraction (%) Pre 24  6
CRT 34  10*
p  0.05 vs. before implantation (Pre). Data are presented as the mean value  SD
CRT  cardiac resynchronization therapy; CSA  central sleep apnea; VE/VCO
onsumption; VO2-AT  VO2 at anaerobic threshold.
igure 1. Effects of cardiac resynchronization therapy (CRT) on apnea
ypopnea index (AHI) in patients with and without central sleep apnea
CSA). The area under the dotted line represents a normal AHI (5).
quares mean SD of all patients; triangles mean SD of patients
ith CSA; octagons  mean  SD of patients without CSA. Stars  pd0.005 vs. baseline.ion (18). This may, in turn, result in reduced pulmonary
ongestion as a triggering factor of the reflex mechanisms
esponsible for Cheyne-Stokes respiration.
We also found a significant decrease in ventilatory re-
ponse to exercise measured by the VE/VCO2 slope in CSA
atients. This points to a reduction in circulation time
etween lungs and peripheral chemoreceptors, as well as a
ecrease in chemoreflex sensitivity to carbon dioxide.
herefore, our findings suggest that impaired LV function
ay be the primary cause of the reflex cascade, leading to
heyne-Stokes respiration, and not vice versa.
Elevated VE/VCO2 slopes (19) and Cheyne-Stokes respi-
ation (2) are associated with increased mortality in HF
atients. Thus, the interruption of this vicious cycle of
heyne-Stokes respiration may have a positive effect on
rognosis.
Although the AHI is the result of a single-night evalu-
tion, we could demonstrate positive long-term effects of
RT on sleep quality. The PSQI was significantly reduced
nd directly related to AHI improvement during CRT.
hese sleep-related effects might contribute to the signifi-
ant improvement of patients’ quality of life, as found in
ther CRT studies (7,8). Based on our findings, the im-
rovement of CSA with Cheyne-Stokes respiration could
e used as a helpful tool to evaluate the efficacy of CRT.
Breathing patterns, like respiration rate and minute
entilation, can be determined by implanted pacemaker
ensors measuring the transthoracic impedance minute ven-
ilation. Several studies have shown a high correlation
etween transthoracic impedance minute ventilation and
ctual minute ventilation measured by standard methods
20,21). Different breathing patterns and daily activities,
ncluding exercise testing, affect the transthoracic imped-
nce minute ventilation (21) and allow one to draw conclu-
ions about the patient’s condition.
Therefore, analysis of breathing patterns may be used to
apacity and Echocardiographic Parameters
CSA
(n  14)
No CSA
(n  10)
p Value
(CSA vs. No CSA)
 5.5 (n  11) 29.4  2.7 (n  7) 0.01
 5.8* (n  11) 28.8  2.8 (n  7) NS
 1.9 (n  11) 10.4  1.6 (n  7) NS
 3.1* (n  11) 13.3  3.4* (n  7) NS
 3.1 (n  11) 12.3  3.0 (n  7) NS
 5.2* (n  11) 16.2  4.4* (n  7) NS
307  122 302  152 NS
409  95* 387  144* NS
243  77 263  80 NS
202  85* 214  92* NS
178  61 209  76 NS
135  69* 153  91* NS
25  5 23  7 NS
35  9* 33  11* NS
ope of increase in ventilation relative to carbon dioxide production; VO2  oxygenise C
36.7
30.6
10.0
13.4
13.1
17.1
.
2  sletermine the choice of CRT devices in the future. Patients
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July 7, 2004:68–71 Effects of CRT on CSAith CSA may benefit from devices with a minute ventila-
ion sensor capable of analyzing specific breathing patterns.
his would allow continuous and noninvasive monitoring of
RT efficacy.
tudy limitations. We applied a single-night cardiorespi-
atory polygraphy, which is used for the initial ambulatory
iagnosis of sleep apnea syndromes (22). Although poly-
omnography is regarded as the “gold standard,” previous
tudies have shown a high diagnostic accuracy of the
ortable recording device (22).
onclusions. In patients receiving CRT, the improvement
f cardiac function and exercise capacity is associated with a
ignificant improvement of CSA with Cheyne-Stokes res-
iration and sleep quality. Therefore, the analysis of breath-
ng patterns could be used for device-based monitoring of
RT efficacy in the future. Further studies are necessary to
valuate the prognostic implications of breathing pattern
nalysis in HF patients receiving CRT.
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